Jérôme Giustiniani

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Jérémy Bastid, Anne Regairaz, Nathalie Bonnefoy et al. · Cancer Immunology Research · 2014 · 237 citations

Cd39 Enzymatic Function, T-regulatory Cell, Immunology +25

Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells

Pierre Fons, Sophie Chabot, Judith E. Cartwright et al. · Blood · 2006 · 194 citations

Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity

Philippe Le Bouteiller, Alíz Barakonyi, Jérôme Giustiniani et al. · Proceedings of the National Academy of Sciences · 2002 · 134 citations · Full text

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

Stéphanie Cochaud, Jérôme Giustiniani, Clémence Thomas et al. · Scientific Reports · 2013 · 134 citations · Full text

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome

J. Plée, Sébastien Le Jan, Jérôme Giustiniani et al. · Scientific Reports · 2015 · 78 citations · Full text